Stocks
GlaxoSmithKline (GSK) ROA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | 8.18% | 8.35% | 6.55% | 4.33% | 9.37% | 7.03% | ||
| Changes by years, y/y, % | -17pp | +0pp | -2pp | -2pp | +5pp | +5.6% | |||
GlaxoSmithKline. ROA, %
GlaxoSmithKline. ROA, changes, pp
GlaxoSmithKline (GSK) ROA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| ROA, % | ? | 4.02% | 4.22% | 6.65% | 9.37% | 7.03% | 7.03% | |
| Changes by years, y/y, % | -4pp | -3pp | +2pp | +5pp | +3pp | |||
| Changes by quarters, q/q, % | 0pp | +0pp | +2pp | +3pp | -2pp | |||
